Dydrogesterone
Term · Oncology and biomedicine · MLC-T-ONC-013192
A synthetic, orally active progestin that may be useful in the treatment of disorders attributed to progesterone deficiency. Upon administration, dydrogesterone binds to progesterone receptors with high affinity and helps regulate the healthy growth and normal shedding of the uterine lining. Dydrogesterone appears to have no affinity for androgenic, estrogenic, glucocorticoid or mineralocorticoid receptors.
| Identifier | MLC-T-ONC-013192 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | didrogesterone; isopregnenone; hydrogestrone |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013192",
"term": "Dydrogesterone",
"field": "Oncology and biomedicine",
"definition": "A synthetic, orally active progestin that may be useful in the treatment of disorders attributed to progesterone deficiency. Upon administration, dydrogesterone binds to progesterone receptors with high affinity and helps regulate the healthy growth and normal shedding of the uterine lining. Dydrogesterone appears to have no affinity for androgenic, estrogenic, glucocorticoid or mineralocorticoid receptors.",
"synonyms": [
"didrogesterone",
"isopregnenone",
"hydrogestrone"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dydrogesterone/"
}
Record 6,310 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.